Anti-TOMM20 antibody [EPR15581-39] - Mitochondrial Marker (Ab186734)

What is this antibody validated in? Anti-TOMM20 antibody [EPR15581-39] - Mitochondrial Marker (ab186734) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples. What is the molecular weight of TOMM20? Anti-TOMM20 [EPR15581-39] - Mitochondrial Marker (ab186734) specifically detects a band for TOMM20 (UniProt: Q15388) at a molecular weight of 16kDa. Trusted by the scientific community Anti-TOMM20 [EPR15581-39] - Mitochondrial Marker (ab186734) was first used in a scientific publication in 2014 and has been cited over 90 times in peer-reviewed journals. Reviewed by scientists Anti-TOMM20 [EPR15581-39] - Mitochondrial Marker (ab186734) has over 5 independent reviews from customers. Other related products We have a range of other formats of antibody clone [EPR15581-39] also available for your convenience: ab186734, Alexa Fluor ® 488 - ab205486, Alexa Fluor ® 647 - ab205487, HRP - ab205796, Alexa Fluor ® 555 - ab214409, Carrier free - ab220822, ab283317, Carrier free - ab283339, ab289670, Carrier free - ab289676, Alexa Fluor ® 488 - ab309083, Alexa Fluor ® 647 - ab309166, Alexa Fluor ® 647 - ab309167 Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.